Follow

Awesome: Pharma companies begrudgingly agree to negotiate prices

Merck, AstraZeneca, Bristol Myers Squibb, and Boehringer Ingelheim have all said that they will agree to the negotiations, though some were clearly bitter about it.

If the drug makers reject the negotiations, they would either face an excise tax of up to 95 percent of the drugs' sales, or have to pull all of their drugs from the Medicare and Medicaid markets.

arstechnica.com/health/2023/09

@b4cks4w We'll still have to see how the court cases play out, but this is really good news.

I will be really excited to see some actual progress here.

It looks so far like Congress actually passed something to help people. Quite welcome.

Sign in to participate in the conversation

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.